Viewing Study NCT03092895


Ignite Creation Date: 2025-12-24 @ 1:36 PM
Ignite Modification Date: 2026-01-29 @ 5:18 PM
Study NCT ID: NCT03092895
Status: COMPLETED
Last Update Posted: 2023-02-08
First Post: 2017-03-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of SHR-1210 in Combination With Apatinib or Chemotherapy in Subjects With Advanced PLC or BTC
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: SHR-1210-APTN-II-203-PLC
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators